Logo image of NSPR

INSPIREMD INC (NSPR) Stock Price, Quote, News and Overview

NASDAQ:NSPR - Nasdaq - US45779A8466 - Common Stock - Currency: USD

2.46  -0.03 (-1.2%)

NSPR Quote, Performance and Key Statistics

INSPIREMD INC

NASDAQ:NSPR (5/28/2025, 3:53:35 PM)

2.46

-0.03 (-1.2%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High3.8
52 Week Low2.07
Market Cap75.37M
Shares30.64M
Float19.79M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-04 2025-08-04/bmo
IPO04-12 2013-04-12


NSPR short term performance overview.The bars show the price performance of NSPR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

NSPR long term performance overview.The bars show the price performance of NSPR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 20 30

The current stock price of NSPR is 2.46 USD. In the past month the price increased by 7.33%. In the past year, price decreased by -9.45%.

INSPIREMD INC / NSPR Daily stock chart

NSPR Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ALC ALCON INC 28.46 42.66B
COO COOPER COS INC/THE 21.25 16.02B
ALGN ALIGN TECHNOLOGY INC 19.3 13.05B
SOLV SOLVENTUM CORP 12.21 12.57B
MMSI MERIT MEDICAL SYSTEMS INC 26.45 5.58B
LNTH LANTHEUS HOLDINGS INC 11.21 5.13B
BLCO BAUSCH + LOMB CORP 23.88 4.05B
HAE HAEMONETICS CORP/MASS 14.79 3.40B
XRAY DENTSPLY SIRONA INC 9.83 3.29B
ICUI ICU MEDICAL INC 18.41 3.16B
UFPT UFP TECHNOLOGIES INC 28.02 1.77B
NEOG NEOGEN CORP 16.08 1.33B

About NSPR

Company Profile

NSPR logo image InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Company Info

INSPIREMD INC

4 Menorat Hamaor St.

TEL AVIV-YAFO 6744832 IL

CEO: Marvin Slosman

Employees: 85

NSPR Company Website

NSPR Investor Relations

INSPIREMD INC / NSPR FAQ

What is the stock price of INSPIREMD INC today?

The current stock price of NSPR is 2.46 USD. The price decreased by -1.2% in the last trading session.


What is the ticker symbol for INSPIREMD INC stock?

The exchange symbol of INSPIREMD INC is NSPR and it is listed on the Nasdaq exchange.


On which exchange is NSPR stock listed?

NSPR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INSPIREMD INC stock?

8 analysts have analysed NSPR and the average price target is 4.85 USD. This implies a price increase of 96.95% is expected in the next year compared to the current price of 2.46. Check the INSPIREMD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INSPIREMD INC worth?

INSPIREMD INC (NSPR) has a market capitalization of 75.37M USD. This makes NSPR a Micro Cap stock.


How many employees does INSPIREMD INC have?

INSPIREMD INC (NSPR) currently has 85 employees.


What are the support and resistance levels for INSPIREMD INC (NSPR) stock?

INSPIREMD INC (NSPR) has a support level at 2.35 and a resistance level at 2.57. Check the full technical report for a detailed analysis of NSPR support and resistance levels.


Is INSPIREMD INC (NSPR) expected to grow?

The Revenue of INSPIREMD INC (NSPR) is expected to grow by 26.95% in the next year. Check the estimates tab for more information on the NSPR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INSPIREMD INC (NSPR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INSPIREMD INC (NSPR) stock pay dividends?

NSPR does not pay a dividend.


When does INSPIREMD INC (NSPR) report earnings?

INSPIREMD INC (NSPR) will report earnings on 2025-08-04, before the market open.


What is the Price/Earnings (PE) ratio of INSPIREMD INC (NSPR)?

INSPIREMD INC (NSPR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.79).


What is the Short Interest ratio of INSPIREMD INC (NSPR) stock?

The outstanding short interest for INSPIREMD INC (NSPR) is 0.78% of its float. Check the ownership tab for more information on the NSPR short interest.


NSPR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NSPR. When comparing the yearly performance of all stocks, NSPR is a bad performer in the overall market: 79.37% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NSPR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NSPR. While NSPR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NSPR Financial Highlights

Over the last trailing twelve months NSPR reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS decreased by -3.95% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -68.38%
ROE -88.69%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-4.76%
Sales Q2Q%1.19%
EPS 1Y (TTM)-3.95%
Revenue 1Y (TTM)12.96%

NSPR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to NSPR. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -24.23% and a revenue growth 26.95% for NSPR


Ownership
Inst Owners40.55%
Ins Owners20.74%
Short Float %0.78%
Short Ratio3.27
Analysts
Analysts82.5
Price Target4.85 (97.15%)
EPS Next Y-24.23%
Revenue Next Year26.95%